Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Microbes Infect. 2014 Jul;16(7):529-31. doi: 10.1016/j.micinf.2014.05.002. Epub 2014 Jun 12.

Calling for rapid development of a safe and effective MERS vaccine.

Author information

  • 1Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA. Electronic address: hotez@bcm.edu.
  • 2Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA.
  • 3Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
  • 4Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th Street, New York, NY, USA.
  • 5Lindsley F. Kimball Research Institute, New York Blood Center, 310 East 67th Street, New York, NY, USA; Key Laboratory of Medical Molecular Virology of MOE/MOH, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, China. Electronic address: shibojiang@fudan.edu.cn.

Abstract

The geographic spread and rapid increase in the cases of Middle East respiratory syndrome (MERS) caused by a novel coronavirus (MERS-CoV) during the past two months have raised concern about its pandemic potential. Here we call for the rapid development of an effective and safe MERS vaccine to control the spread of MERS-CoV.

Copyright © 2014. Published by Elsevier Masson SAS.

KEYWORDS:

Coronavirus; MERS-CoV; Receptor; Receptor-binding domain; Vaccine

PMID:
24931059
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk